Jessica F. Burlile
MedStar Georgetown University Hospital, Georgetown University
Papers
2
Total Citations
8
H-Index
2
About
Jessica F. Burlile is a clinical researcher whose work sits at the intersection of radiation oncology and patient quality of life, with a particular focus on prostate cancer treatment. Her research centers on understanding how androgen deprivation therapy (ADT) combined with stereotactic body radiotherapy (SBRT) affects hormonal recovery and patient well-being. Burlile’s major contribution lies in establishing testosterone as a critical biomarker for quality of life outcomes following these treatments. Her most cited study (2023, 6 citations) demonstrated that testosterone recovery kinetics directly correlate with improvements in patient-reported hormonal and sexual function, providing clinicians with a measurable endpoint to guide treatment decisions. In earlier work (2019, 2 citations), she showed that short-course ADT with SBRT leads to predictable testosterone recovery patterns that closely mirror improvements in patient-reported outcomes. This research has practical implications for personalizing treatment duration and managing patient expectations. Burlile’s work bridges the gap between objective biomarkers and subjective patient experience, offering a more nuanced understanding of how aggressive cancer therapies impact long-term quality of life. Her findings help oncologists balance treatment efficacy with the hormonal side effects that matter most to patients.
Research Focus
Key Achievements
Top Papers
- 1
- 2